Concepedia

Stéphanie Chanteux

SC

Statistics

Publications

4

Citations

508

H-Index

4

Active since

2014

Affiliations

Innate Pharma (France)(Current)

Inserm

Université Paris Cité

Délégation Paris 7

Stéphanie Chanteux is an author at Innate Pharma (France) specializing in tumor immunity, cancer research, and immunology.

Top concepts

Publications per year

2014–2019

4

Publications

4

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli et al. · Cell Reports · 2019 · 404 citations · Full text

, , +15

IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma

Anne Marie‐Cardine, Nicolas Viaud, Nicolas Thonnart et al. · Cancer Research · 2014 · 73 citations

The D0 Ig-like Domain Plays a Central Role in the Stronger Binding of KIR3DL2 to B27 Free H Chain Dimers

Hiroko Hatano, Jacqueline Shaw, K Marquardt et al. · The Journal of Immunology · 2015 · 21 citations · Full text

Abstract 2713: Preclinical development of first-in-class antibodies targeting Siglec-9 immune checkpoint for cancer immunotherapy

Olivier Bénac, Marion Gaudin, Mélody Ors et al. · Cancer Research · 2018 · 10 citations

, , +24

1–4 of 4